During the past decade, Lake Internal Medicine Associates conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Lake Internal Medicine Associates" are "Chronic Idiopathic Constipation" (1 trials), "Chronic Low Back Pain" (1 trials), "Diabetic Neuropathy Peripheral" (1 trials), "Metapneumovirus" (1 trials) and "Osteoarthritis, Hip" (1 trials). Many other conditions were trialed in "Lake Internal Medicine Associates" in a lesser frequency.

Most popular intervention types in "Lake Internal Medicine Associates" are "Drug" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Active Provant Therapy System" (1 trials), "COV155" (1 trials), "Elobixibat 10 mg/day" (1 trials) and "Elobixibat 5 mg/day" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lake Internal Medicine Associates" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Lake Internal Medicine Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Lake Internal Medicine Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Lake Internal Medicine Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".